The majority of BC cases is represented by human epidermal growth factor receptor 2 (HER2)-negative, hormone receptor (HR, estrogen (ER) and progesterone (PR) receptor)-positive (HR+/HER2−) tumors. This evidence concerns the gene HR and breast cancer.